Pfizer Inc (NYSE:PFE)
$ 28.01 -0.17 (-0.6%) Market Cap: 158.72 Bil Enterprise Value: 215.50 Bil PE Ratio: 0 PB Ratio: 1.72 GF Score: 77/100

Pfizer Inc Virtual Investor Day: Day 1 Transcript

Sep 14, 2020 / 05:00PM GMT
Release Date Price: $35.06 (+2.61%)
Charles E. Triano
Pfizer Inc. - SVP of IR

Welcome, everyone, and thanks for joining us virtually for our first of 2 sessions, where we will share some exciting updates from Pfizer's portfolio and R&D pipeline. Today's program will be a combination of prerecorded prepared remarks and then, of course, live audience Q&A sections. Today, we'll hear from members of our executive leadership team as well as leaders of our Internal Medicine and Vaccines teams, the 2 therapeutic areas in focus for today's session. We will have a Q&A session following each of the therapeutic area presentations.

The presentation at today's Investor Day include forward-looking statements about, among other things, our anticipated future operating and financial performance, business plans and prospects and expectations for our product pipeline our in-line products and product candidates. By their nature, all these statements about future events and expectations for our pipeline products are forward-looking. Each forward-looking statement contained in these presentations is subject to risks and uncertainties that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot